USPTO serial 79160999
SOL-LUTION
Reviewed by CopyMark Law Group
Reg. 5024394Status 404
- Filing date
- Status date
- Registration date
- Aug 23, 2016
- Examiner
- GLASSER, CARYN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with SOL-LUTION?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
DE
DE
DE
DE
DE
DE
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of gingivitis, emesis, neuropathic pain, muscle spasticity, neurodermatitis, psoriasis, halitosis, stomatitis, periodontitis, inflammation of the oral cavity and pharyngeal cavity, hypersensitivity of teeth, angina, atherosclerosis, bronchial asthma, circulatory disorders, constipation, diarrhoea, heart failure, heart rhythm disorders, high blood pressure, indigestion, insomnia, migraine, motion sickness, nausea, peptic ulcers, vomiting, allergy, gynaecological disorders affecting menstruation, sterility, menstrual syndromes, dysmenorrhoea, infertility, genital tract infections, pelvic inflammatory diseases, vaginal discomfort due to menopausal atrophic changes, anatomical abnormalities of the head, the extremities, chest, abdomen and organs, neoplasia, breast neoplasm, breast cancer, mastopathy, mastodynia, premenstrual syndrome, climateric complaints, breast pain, blood conditions and disorders, blood circulation disorders, high blood pressure, hypertension, pulmonary diseases, heart rhythm disorders, heart failure, urological diseases, sexually transmitted diseases and inflammatory pelvic diseases, menopausal complaints due to therapeutically induced menopause, tamoxifen induced hot flushes of breast cancer survivors, climactic sleep disturbances, depressive moods, protection of the skeletal system, osteoporosis, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, psycho vegetative disorders, depressive syndrome, anxiety, nervous unrest, peripheral nervous system infections, peripheral nervous system movement disorders, nerve compression syndromes, neuritis, neuralgia and regional pain syndromes, diseases and disorders of the kidney, urological disorders, chronic infections of the bladder, cystitis, pyelonephritis, glomerulonephritis, interstitial nephritis, nephrolithiasis, cancer, urolith prophylaxis, dizziness, migraine, depression, inflammations of the upper and lower respiratory organs, sinuses, bronchitis, tonsillitis, arthritis, osteoarthritis, fever, cough, cold, Alzheimer's disease, infection of respiratory tract, infection of urinary tract, urinary obstruction, chronic venous insufficiency, prostate hyperplasia, muscle pains, soft tissue rheumatism, musculoskeletal disease, liver disease, hepatitis, cirrhosis of liver, periodontal diseases and dental caries, occasional minor irritation, pain, sore mouth, sore gums, sore throat, pain associated with canker sores, pain due to minor irritation or injury of the mouth and gums, pain due to minor dental procedures, pain due to minor irritations caused by dentures or orthodontic appliances, sore gums due to teething in infants and children four months of age and older; medical and veterinary preparations and articles, namely, preparations for the treatment of gingivitis, emesis, neuropathic pain, muscle spasticity, neurodermatitis, psoriasis, halitosis, stomatitis, periodontitis, inflammation of the oral cavity and pharyngeal cavity, hypersensitivity of teeth, angina, atherosclerosis, bronchial asthma, circulatory disorders, constipation, diarrhoea, heart failure, heart rhythm disorders, high blood pressure, indigestion, insomnia, migraine, motion sickness, nausea, peptic ulcers, vomiting, allergy, gynaecological disorders affecting menstruation, sterility, menstruation syndromes, dysmenorrhoea, infertility, genital tract infections, pelvic inflammatory diseases, vaginal discomfort due to menopausal atrophic changes, anatomical abnormalities of the head, the extremities, chest, abdomen and organs, neoplasia, breast neoplasm, breast cancer, mastopathy, mastodynia, premenstrual syndrome, climateric complaints, breast pain, blood conditions and disorders, blood circulation disorders, high blood pressure, hypertension, pulmonary diseases, heart rhythm disorders, heart failure, urological diseases, sexually transmitted diseases and inflammatory pelvic diseases, menopausal complaints due to therapeutically induced menopause, tamoxifen induced hot flushes of breast cancer survivors, climactic sleep disturbances, depressive moods, protection of the skeletal system, osteoporosis, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, psycho vegetative disorders, depressive syndrome, anxiety, nervous unrest, peripheral nervous system infections, peripheral nervous system movement disorders, nerve compression syndromes, neuritis, neuralgia and regional pain syndromes, diseases and disorders of the kidney, urological disorders, chronic infections of the bladder, cystitis, pyelonephritis, glomerulonephritis, interstitial nephritis, nephrolithiasis, cancer, urolith prophylaxis, dizziness, migraine, depression, inflammations of the upper and lower respiratory organs, sinuses, bronchitis, tonsillitis, arthritis, osteoarthritis, fever, cough, cold, Alzheimer's disease, infection of respiratory tract, infection of urinary tract, urinary obstruction, chronic venous insufficiency, prostate hyperplasia, muscle pains, soft tissue rheumatism, musculoskeletal disease, liver disease, hepatitis, cirrhosis of liver, periodontal diseases and dental caries, occasional minor irritation, pain, sore mouth, sore gums, sore throat, pain associated with canker sores, pain due to minor irritation or injury of the mouth and gums, pain due to minor dental procedures, pain due to minor irritations caused by dentures or orthodontic appliances, sore gums due to teething in infants and children four months of age and older, articles being medical plasters, medical materials for dressings, namely, gauze and bandages; dietetic preparations, namely, dietetic sugar for medical use, dietary and nutritional supplements used for weight loss, protein supplement shakes for weight gain purposes, chocolate-based meal replacement shakes for weight loss purposes; dietetic food and substances adapted for medical or veterinary use, namely, dietetic herbal teas, vitamin and mineral supplements, dietic food supplements based on amino acids, minerals and/or trace elements, dietary vitamin and mineral beverages; dietary supplements; dental preparations and articles, namely, medicated dental, gum and mouth washes, medicated dental, gum and mouth rinse, medicated toothpastes, medicated oral-care gels, medicated dental gels, medicated lozenges, cough lozenges, medicated chewing gum, medicated gels and fluids in the nature of medicated balms, medicated dental tapes, medicated dental ribbons, medicated dental polish, plaque disclosing reagents, periodontal diagnostic reagents for medical purposes for detecting derivatives from periodontal bacteria and caries, diagnostic reagents for detecting derivatives from caries-causing bacteria and medicines for the prevention and treatment of periodontal diseases, dental caries, canker sores, cold sores, mucositis and oral and tongue cancers, material for stopping teeth, dental wax | SECTION 71 - CANCELLED | — |
| 035 | Business management; business administration; office functions; advertising; marketing and promotional services; business contact services, namely, provision of commercial and business contact information, connecting qualified service providers with consumers, arranging of contractual services with third parties, providing an online computer database in the field of business information and business contacts; collective buying services, namely, purchasing pharmaceutical preparations, medical and veterinary preparations and articles, dietetic preparations, dietetic food and drinks, dietary and nutritional supplements, and cosmetics for others; commercial evaluation services, namely, evaluation relating to commercial matters; distributorship services in the field of pharmaceutical preparations, medical and veterinary preparations and articles, dietetic preparations, dietetic food and drinks, dietary and nutritional supplements, and cosmetics; import and export services; negotiation and conclusion of commercial transactions for third parties; procurement services for others, namely, purchasing pharmacy furniture and devices; business assistance, business management and administrative services, namely, processing of purchase orders, filing business formation documents; business analysis, research and information services; business auditing; business mediation services for third parties; advice, consultancy and information for the aforesaid | SECTION 71 - CANCELLED | — |
| 036 | Equity financing services for start-up companies and small businesses in the field of pharmacy, nutritional supplements, cosmetics, food, drinks and plant extracts | SECTION 71 - CANCELLED | — |
| 042 | Development of pharmaceutical preparations and medicines; IT services, namely, software development, programming and implementation, computer hardware development, hosting services, namely, hosting of websites; software as a service featuring software for use in database management, for accounting, for financial analysis, and rental of software-; rental of computer hardware and computer peripherals; IT consultancy, advisory and information services, IT security, namely, testing of security systems, maintenance of computer software relating to computer security and prevention of computer risks, media data duplication and conversion services of electronic information; data coding, namely, data encryption services; computer system analysis and diagnostics; research, development and implementation of computers and systems; computer project management services; data mining; digital watermarking; computer consultation services; technological services relating to computers, namely, technological planning and consulting services in the field of computer hardware systems; computer network configuration services; updating of memory banks of computer systems; data migration services; updating websites for others; monitoring of computer systems by remote access to ensure proper functioning; testing, authentication and quality control, namely, product safety testing, product quality testing, testing, inspection or research of pharmaceuticals to ensure compliance with pharmaceutical and medical standards; design services, namely, color analysis for purposes of interior design of pharmacies, design of web sites for others, design of home pages, design of interior decor of pharmacies; all aforesaid services not in relation to consultancy in regard of building design services and building construction; rental of computer hard and computer software; leasing of computer programs, leasing of computers | SECTION 71 - CANCELLED | — |
| 045 | Licensing and authority services, namely, licensing of intellectual property; legal registration services-, namely, domain name registration services; and registration of company names; legal services; advice, consultancy and information for the aforesaid, included in this class | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Dermapharm Aktiengesellschaft
- Other trademarks owned by Spectrum Therapeutics GmbH
- Other trademarks owned by Bionorica Ethics GmbH
- Other trademarks owned by Bionorica SE
- Other trademarks owned by Bionorica SE
- Other trademarks owned by Bionorica SE
- Other trademarks in Class 005
- Other trademarks in Class 035
- Other trademarks in Class 036
- Other trademarks in Class 042
- Other trademarks in Class 045
- Similar marks named SOL-LUTION
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 20, 2025 | LIMN | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Apr 25, 2025 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Oct 26, 2024 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Oct 17, 2024 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Aug 9, 2024 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Nov 26, 2023 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Nov 3, 2023 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Nov 3, 2023 | INPC | INVALIDATION PROCESSED | — |
| Nov 3, 2023 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Mar 3, 2023 | C71T | CANCELLED SECTION 71 | — |
| May 21, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 4, 2019 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Jul 8, 2017 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Feb 17, 2017 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 26, 2017 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 26, 2017 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Nov 23, 2016 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 23, 2016 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 12, 2016 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jul 27, 2016 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 27, 2016 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jun 7, 2016 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 18, 2016 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 18, 2016 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| May 18, 2016 | NPUB | NOTICE OF PUBLICATION | — |
| May 4, 2016 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Apr 27, 2016 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 27, 2016 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Apr 27, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 18, 2016 | PAPER RECEIVED | — | |
| Nov 16, 2015 | LIMN | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Oct 27, 2015 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 26, 2015 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 23, 2015 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Oct 20, 2015 | DMCC | DATA MODIFICATION COMPLETED | — |
| Oct 20, 2015 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Oct 20, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 18, 2015 | ALIE | ASSIGNED TO LIE | — |
| Sep 3, 2015 | PAPER RECEIVED | — | |
| Mar 27, 2015 | RFNP | REFUSAL PROCESSED BY IB | — |
| Mar 9, 2015 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 9, 2015 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 7, 2015 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 6, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 3, 2015 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 27, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 27, 2015 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 26, 2015 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |